AI assistant
Sun Pharmaceutical Industries Ltd. — Major Shareholding Notification 2020
Jun 2, 2020
59215_rns_2020-06-02_9fa34b63-3145-4f55-aa6c-7b8fa44346b5.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Dilip Shanghvi
Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai - 400 063. Maharashtra, INDIA. Tel.: (91-22) 4324 4324, Fax: (91-22) 4324 4343 E-mail: [email protected]
May 30, 2020
National Stock Exchange of India Ltd, BSE Limited, Exchange Plaza, 5th Floor, Market Operations Department Plot No. C/1, G Block, P. J. Towers, Bandra Kurla Complex, Dalal Street, Bandra (East), Mumbai – 400 051. Mumbai - 400 001. Scrip Code: SUNPHARMA Scrip Code: 524715
Dear Sir / Madam,
Sub: a) Disclosures under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
b) Declaration under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
-
a) Please find enclosed herewith the disclosure of shareholding in Sun Pharmaceutical Industries Limited (“Target Company”) as on March 31, 2020, in terms of regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 in the prescribed format.
-
b) I, Dilip S. Shanghvi, promoter of Target Company hereby declare that, as on March 31, 2020, I along with Promoter Group and Persons acting in concert has not made any encumbrance, directly or indirectly, on the shares of the Target Company, other than those already disclosed during the financial year.
This is for your information and record.
Thanking you,
Yours faithfully,
SHANGHVI Digitally signed by SHANGHVI DILIP DILIP SHANTILAL Date: 2020.05.30 SHANTILAL 16:33:42 +05'30'
Dilip S. Shanghvi
Encl: As above
Copy to: The Company Secretary, The Audit Committee Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, SPARC, Tandalja, SPARC, Tandalja, Vadodara – 390 012 Vadodara – 390 012 Gujarat, India. Gujarat, India.
Dilip Shanghvi
Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai - 400 063. Maharashtra, INDIA. Tel.: (91-22) 4324 4324, Fax: (91-22) 4324 4343 E-mail: [email protected]
Disclosures under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 as on March 31, 2020
Sun Pharmaceutical Industries Limited
- Name of the Target Company (TC)
1. National Stock Exchange of India Limited 2. BSE Limited
- Name(s) of the stock exchange(s) where the shares of the TC are listed
| 1. Name of the Target Company (TC) | 1. Name of the Target Company (TC) | Sun Pharmaceutical Industries Limited |
|---|---|---|
| 2. Name(s) of the stock exchange(s) where the shares of the TC are listed |
1. National Stock Exchange of India Limited 2. BSE Limited |
|
| 3. Particulars of the shareholder(s) : a) Name of person(s) together with Persons Acting in Concert (PAC) whose total holding (including that in the form of shares, warrants, convertible securities and any other instrument that would entitle the holder to receive shares in the TC) is more than 25% of the voting rights of the TC. or b) Name(s) of promoter(s), member of the promoter group and PAC with him. |
Promoter: Mr. Dilip S. Shanghvi Persons forming part of the Promoter Group: Shanghvi Finance Private Limited Aditya Medisales Limited Mr. Sudhir V. Valia Mrs.Vibha D. Shanghvi Mr. Aalok D. Shanghvi Ms. Vidhi D. Shanghvi Shanghvi Family & Friends Benefit Trust (Kumud S. Shanghvi and Dilip S. Shanghvi are Trustees) Mrs. Kumud S. Shanghvi Flamboyawer Finance Private Limited Sanghvi Properties Private Limited Gujarat Sun Pharmaceutical Industries Private Limited Persons Acting in Concert : Mrs. Raksha S. Valia Unimed Investments Limited |
- Particulars of the shareholder(s) :
Dilip Shanghvi
Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai - 400 063. Maharashtra, INDIA. Tel.: (91-22) 4324 4324, Fax: (91-22) 4324 4343 E-mail: [email protected]
| 4. Particulars of the shareholding of person(s) mentioned at (3) above |
Number of shares as on 31.03.2020 |
% w.r.t. total share /voting capital wherever applicable |
% of total diluted share/voting capital of TC (*) |
|---|---|---|---|
| As of March 31stof the year 2020, holding of: | |||
| a) Shares | |||
| Promoter | |||
| Mr. Dilip S.Shanghvi | 230,285,690 | 9.60 |
9.60 |
| Members of Promoter Group | |||
| Shanghvi Finance Private Limited$ | 967,051,732 | 40.30 |
40.30 |
| Aditya Medisales Limited | 40,153,960 | 1.67 |
1.67 |
| Mr. Sudhir V. Valia | 14,345,019 | 0.60 |
0.60 |
| Mrs. Vibha D. Shanghvi | 8,840,280 | 0.37 |
0.37 |
| Mr. Aalok D. Shanghvi | 2,877,280 | 0.12 |
0.12 |
| Ms. Vidhi D. Shanghvi | 2,822,427 | 0.12 |
0.12 |
| Shanghvi Family & Friends Benefit Trust (Kumud S. Shanghvi and Dilip S. Shanghvi are Trustees) |
1,276,774 |
0.05 |
0.05 |
| Mrs. Kumud S. Shanghvi | 199,465 | 0.01 |
0.01 |
| Flamboyawer Finance Private Limited | 20,865 | 0.00 |
0.00 |
| Sanghvi Properties Private Limited | 15,479 | 0.00 |
0.00 |
| Gujarat Sun Pharmaceutical Industries Private Limited |
14,362 | 0.00 |
0.00 |
| Persons Acting in Concert | |||
| Mrs. Raksha S. Valia | 33,830,352 | 1.41 |
1.41 |
| Unimed Investments Limited | 10,400,850 | 0.43 |
0.43 |
| Total (a) | 1,312,134,535 | 54.69 |
54.69 |
| b) Voting Rights (otherwise than by shares) | NA | NA | NA |
| c) Warrants | NA | NA |
NA |
| d) Convertible Securities | NA | NA |
NA |
| e) Any other instrument that would entitle the holder to receive shares in the TC. |
NA | NA |
NA |
| Total | 1,312,134,535 |
54.69 | 54.69 |
Dilip Shanghvi
Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai - 400 063. Maharashtra, INDIA. Tel.: (91-22) 4324 4324, Fax: (91-22) 4324 4343 E-mail: [email protected]
Part-B Name of the Target Company: Sun Pharmaceutical Industries Limited**
| Name(s) of the person and Persons Acting in Concert (PAC) with the person |
Whether the person belongs to Promoter/ Promoter group |
PAN of the person and PACs |
| Promoter | ||
| Mr. Dilip S.Shanghvi | Yes | AMPPS4862F |
| Members of Promoter Group | ||
| Shanghvi Finance Private Limited | Yes | AAACS6963R |
| Aditya Medisales Limited | Yes | AABCA9317J |
| Mr. Sudhir V Valia | Yes | AABPV2199J |
| Mrs. Vibha D. Shanghvi | Yes | ANIPS2068P |
| Mr. Aalok D. Shanghvi | Yes | AXLPS4835P |
| Ms. Vidhi D. Shanghvi | Yes | BCMPS0940L |
| Shanghvi Family & Friends Benefit Trust | Yes | AAATS0789G |
| Mrs. Kumud S. Shanghvi | Yes | ALXPS1387G |
| Flamboyawer Finance Private Limited | Yes | AAACF0545L |
| Sanghvi Properties Private Limited | Yes | AAACS5663E |
| Gujarat Sun Pharmaceutical Industries Private Limited | Yes | AABCG4575G |
| Persons Acting in Concert | ||
| Mrs. Raksha S. Valia | Yes | AAFPV5596F |
| Unimed Investments Limited | Yes | AAACU2965P |
Notes:
$ Pursuant to the Scheme of Amalgamation, effective from 23.10.2018, 1) erstwhile Family Investment Private Limited; and 2) erstwhile Asawari Investment and Finance Private Limited (collectively referred to as the “Amalgamated Companies”) have inter alia got amalgamated with Shanghvi Finance Private Limited (“SFPL”) which is a part of the Promoter Group of the Target Company and thereby the shares held by erstwhile Amalgamated Companies in the Target Company stand transferred in the name of SFPL. SFPL is in the process of getting the Demat account(s) transferred, which are presently in name of erstwhile Amalgamated Companies, to the name of SFPL.
In addition to above, one of the demat accounts in the name of erstwhile Sholapur Organics Private Limited (which also pursuant to the above referred Scheme of Amalgamation got amalgamated with SFPL) got transferred in the name of SFPL but the PAN has not been updated by the Depository Participant and still reflects the PAN of erstwhile Sholapur Organics Private Limited.
In view of the above, for the purpose of this disclosure, the shares held in such Demat account(s) and under PAN of erstwhile Sholapur Organics Private Limited have been clubbed with the shareholding of SFPL
Dilip Shanghvi
Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai - 400 063. Maharashtra, INDIA. Tel.: (91-22) 4324 4324, Fax: (91-22) 4324 4343 E-mail: [email protected]
Mr. Jayant S. Sanghvi, Mrs. Varsha K. Doshi, Mrs. Dipti N. Modi, Mr. Kirit Valia, Kirit Valia HUF, Mr. Jitendra V. Valia, Jitendra Valia HUF, Mr. Ajay V. Valia and Pratham Investments (held on behalf of the firm by its partners) have been re-classified from Promoter Group Category to Public Category vide receipt of approval from National Stock Exchange of India Limited on October 07, 2016 and BSE Limited on October 10, 2016 as per the applicable guidelines/rules and therefore the names of these reclassified persons/ entities have not been included in the above list.
-
(*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.
-
(**) Part-B shall be disclosed to the Stock Exchanges but shall not be disseminated
SHANGHVI Digitally signed by SHANGHVI DILIP DILIP SHANTILAL SHANTILAL Date: 2020.05.30 16:34:30 +05'30'
Dilip S. Shanghvi
Place: Mumbai Date: May 30, 2020